IDT Australia Limited

A$0.04As of Sun 8 Nov 2026, 12:00 UTC
ASX:IDTHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (16.86%)
Div yield —
ROE (13.28%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.02
PE TTM —
TSR TTM (40.00%)
Mkt cap A$15.38M
ROIC (3.26%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0383
6.39%
(88.74%)
Hold 3|5|8|1|3
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
14.32%
12.32%
9.49%
23.50%
Revenue$M
1.765
1.850
1.868
1.868
9.34%
13.70%
12.00%
11.10%
Peers (US$10.56M)
Cap (US$)
PE
5.703M
0.342x
Capital
TTM
5Y
10Y
Leveragex
1.076
2.977
2.377
EBIT/Intx
1.450
0.112
0.105
Own earn%
48.22
(7.89)
2.74
Sh yield%
28.10
31.34
30.00
Owners
Insiders/Inst%
2.79
28.92
Short interest%
5.16
SBC / revenue%
5.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
8–13
$1 testx
—
Incr. ROIC%
3